Skip to main content
. Author manuscript; available in PMC: 2017 Nov 17.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2014 Mar 25;89(2):322–329. doi: 10.1016/j.ijrobp.2014.02.022

Table 3.

Patterns of intracranial progression

Factor Treatment, n (%)
p value
Erlotinib
(n=3 8)
Whole-brain radiation therapy
(n=151)
Stereotactic radiosurgery
(n=10)
Intracranial progression 0.03
 New lesion 8 (21) 7 (47) 7 (70)
 Old lesion 11 (29) 2 (13) 2 (20)
 Both 19 (50) 6 (40) 1(10)